MedTech Daily Briefing
2026-09-05
|
Section 1: MedTech Industry News
Boston Scientific recall of spinal cord stimulator leads tied to more than 1,000 injuries
MedTech Dive • September 04, 2026
|
Boston Scientific begins to restore shipping after cyberattack
MedTech Dive • September 04, 2026
|
Vara receives CE mark for first autonomous breast cancer screening
MedTech Dive • September 04, 2026
|
Globus Medical wins CE mark for Excelsius3D imaging system - MassDevice
MassDevice • September 04, 2026
|
Boston Scientific recalls spinal cord stimulator leads after 1,081 serious injuries - MassDevice
MassDevice • September 05, 2026
|
Philips has a new single-transducer offering for its women’s health ultrasound - MassDevice
MassDevice • September 04, 2026
|
Medtronic says Endurant stent graft’s new CE mark could boost use for ruptured AAA - MassDevice
MassDevice • September 04, 2026
|
Novocure says data exposed in cybersecurity incident - MassDevice
MassDevice • September 04, 2026
|
Novartis Lp(a) drug fails to lower cardiovascular risk in closely watched ph. 3 trial
Fierce Biotech • September 04, 2026
|
Ionis’ ‘breakthrough’ Alexander disease approval establishes pillar of rare disease pipeline
Fierce Biotech • September 04, 2026
|
Menarini signs $771M deal to take Gan & Lee GLP-1 to European market
Fierce Biotech • September 04, 2026
|
|
Section 2: National News — MedTech Relevant
| No relevant national MedTech headlines today. |
|
Section 3: VC Press Releases
|
Section 4: Public Market Roundup — as of September 04, 2026
|
▲ Top Gainers
| PRCT |
Procept |
+6.50% |
| AVR |
Anteris |
+3.67% |
| TMDX |
TransMedics Group |
+3.45% |
|
|
▼ Top Losers
| CLPBY |
Coloplast |
-2.61% |
| TNDM |
Tandem Diabetes Care |
-2.59% |
| BBNX |
Beta Bionics |
-2.51% |
|
📅 Upcoming Earnings (Next 7 Days)
| No earnings expected in the next 7 days. |
|
|
MedTech Daily Briefing • Curated by automation
|
|